- CAS
- 1429311-47-6
- Formula
- C14H18ClN3O4
- MW
- 327.76 g/mol
Rivaroxaban impurity standards
For Rivaroxaban, the Zemixal catalogue holds 97 impurity and reference standards that support release testing, stability programmes and regulatory dossiers. Counted by type, there are 9 pharmacopoeial impurities, 5 nitrosamines, 1 isotope-labelled standard, 6 metabolites or hydroxylated analogues and 3 degradation products.
Batches are supplied with a certificate of analysis, and the supporting spectra can be sent ahead of a purchase order so your QA team can review them. Laboratories use them to validate related-substance methods, set specification limits under ICH Q3A and Q3B, and identify unknown peaks in stability samples. For nitrosamine risk evaluation, the N-nitroso standards allow confirmatory LC-MS testing against the acceptable intake limits.
By impurity type
Counts are based on product names. One compound can fall into more than one type.
All Rivaroxaban reference materials
- CAS
- 1252018-28-2
- Formula
- C14H15ClN2O4
- MW
- 310.73 g/mol
- CAS
- 2304798-51-2
- Formula
- C19H20ClN3O6S
- MW
- 453.9 g/mol
- CAS
- 2137914-93-1
- Formula
- C18H14N2O4
- MW
- 322.3 g/mol
- CAS
- 2733280-11-8
- Formula
- C14H16N2O5
- MW
- 292.29 g/mol
- CAS
- 2422046-61-3
- Formula
- C17H16ClN3O4S
- MW
- 393.8 g/mol
- CAS
- 119835-88-0
- Formula
- C11H11NO4
- MW
- 221.21 g/mol
- CAS
- 931117-61-2
- Formula
- C19H21Cl2N3O6S
- MW
- 490.4 g/mol
- CAS
- 1643354-27-1
- Formula
- C32H30N4O8
- MW
- 598.6 g/mol
- CAS
- 1640884-60-1
- Formula
- C10H12N2O2.ClH
- MW
- 230.67 g/mol
- CAS
- 1450877-56-1
- Formula
- C11H6ClNO4S
- MW
- 283.69 g/mol
- CAS
- 3069765-41-6
- Formula
- C19H19ClN4O7S
- MW
- 482.9 g/mol
- CAS
- 1642600-99-4
- Formula
- C32H30N4O8
- MW
- 598.6 g/mol
- CAS
- 898543-06-1
- Formula
- C14H18ClN3O4
- MW
- 327.76 g/mol